Medicare Enrolled
Dr. Jeffrey Haberman, MD
Urology Physician · Plainview, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Haberman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Haberman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Haberman
Dr. Jeffrey Haberman is an urology physician in Plainview, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Haberman performed 16,604 Medicare services across 6,217 unique beneficiaries.
Between the years covered by Open Payments, Dr. Haberman received a total of $3,702 from 30 pharmaceutical and/or device companies across 126 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Haberman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 5% volume in NY
$3,702 industry payments
Medicare Practice Summary
Medicare Utilization ↗16,604
Medicare services
Top 5% in NY for urology physician
6,217
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~830 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 3,300 | $18 | $49 |
| BCG treatment for bladder cancer | 2,400 | $2 | $9 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
1,932 | $3 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,690 | $111 | $441 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
1,344 | $10 | $48 |
| Leuprolide injectable, camcevi, 1 mg | 1,092 | $69 | $287 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,034 | $77 | $313 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
461 | $12 | $162 |
| PSA test (prostate cancer screening) | 408 | $18 | $55 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
269 | $8 | $9 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
268 | $8 | $24 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
240 | $232 | $991 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
221 | $53 | $209 |
| Injection, amikacin sulfate, 100 mg | 155 | $1 | $17 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
128 | $8 | $26 |
| Complicated insertion of bladder tube | 115 | $139 | $535 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
91 | $8 | $24 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
91 | $8 | $24 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
90 | $143 | $579 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
88 | $31 | $227 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
78 | $96 | $394 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
76 | $57 | $220 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
71 | $130 | $495 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
67 | $353 | $1,305 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
66 | $13 | $49 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
62 | $74 | $270 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
55 | $189 | $691 |
| Catheter specimen collection A procedure to collect a specimen using a catheter. This service is available in all places of service. |
53 | $8 | $9 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
48 | $74 | $591 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
48 | $86 | $499 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
47 | $46 | $172 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
46 | $122 | $446 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
45 | $33 | $121 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 45 | $139 | $758 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
44 | $49 | $203 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
43 | $48 | $3,137 |
| Antimicrobial drug detection test A laboratory test used to identify the presence of antibiotics, antifungals, or antivirals in a sample. |
33 | $5 | $14 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
27 | $22 | $273 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
26 | $234 | $1,046 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
24 | $169 | $617 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
24 | $80 | $290 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
24 | $19 | $76 |
| Other procedure on male genital system A surgical or medical intervention performed on the male genital organs that does not fall under other specific categories. |
21 | $263 | $1,305 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $52 | $198 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
19 | $25 | $77 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
18 | $18 | $55 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
15 | $8 | $25 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
14 | $114 | $1,443 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
14 | $393 | $1,435 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
13 | $193 | $4,581 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
31.6% medium
67.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,702
Total received (2018-2024)
Avg $529/year across 7 years
Top 39% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
126
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,702 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$890
2023
$974
2022
$747
2021
$518
2020
$262
2019
$109
2018
$203
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$188
Sumitomo Pharma America, Inc.
$149
SRS Medical Systems, Inc.
$149
PROCEPT BioRobotics Corporation
$147
Teleflex LLC
$118
Bayer Healthcare Pharmaceuticals Inc.
$99
Astellas Pharma US Inc
$26
Tolmar, Inc.
$15
Top 3 companies account for 54.5% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$565
Teleflex LLC
$392
NeoTract Inc.
$316
Dendreon Pharmaceuticals LLC
$312
Sumitomo Pharma America, Inc.
$285
PROCEPT BioRobotics Corporation
$244
Astellas Pharma US Inc
$220
Myovant Sciences Inc.
$175
Bayer Healthcare Pharmaceuticals Inc.
$163
SRS Medical Systems, Inc.
$149
Pfizer Inc.
$118
PFIZER INC.
$104
UROVANT SCIENCES INC
$91
Janssen Scientific Affairs, LLC
$86
TOLMAR Pharmaceuticals, Inc.
$63
Merck Sharp & Dohme LLC
$61
Endo Pharmaceuticals Inc.
$47
COLOPLAST CORP
$41
Bayer HealthCare Pharmaceuticals Inc.
$38
Amgen Inc.
$38
Progenics Pharmaceuticals, Inc.
$26
Blue Earth Diagnostics Limited
$25
Myriad Genetic Laboratories, Inc.
$24
ABBVIE INC.
$22
Rochester Medical Corporation
$20
Coloplast Corp
$19
Telix Pharmaceuticals
$17
Tolmar, Inc.
$15
Olympus America Inc.
$13
ACCORD HEALTHCARE, INC.
$13
Top 3 companies account for 34.4% of all-time payments
Associated products mentioned in payments ›
AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · Axumin · BOTOX · CAMCEVI · CT3000 Pro Base Unit · ELIGARD · ERLEADA · Erleada · GEMTESA · ILLUCCIX · KEYTRUDA · MYRBETRIQ · Myrbetriq · Nubeqa · ORGOVYX · PROLARIS · PROVENGE · PYLARIFY · Porges Coloplast · SpeediCath · UROLIFT · UroLift · UroLift System · VISERA 4K UHD CAMERA CONTROL UNIT · XGEVA · XIAFLEX · XTANDI · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
334
Per 100K population
24.1
County median income
$143,408
Nearest hospital
PLAINVIEW HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Haberman is a clinical cardiology specialist, with above-average Medicare volume (top 5% in NY), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Haberman experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Haberman performed 3,300 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Haberman receive payments from pharmaceutical companies?
Yes. Dr. Haberman received a total of $3,702 from 30 companies across 126 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Haberman's costs compare to other urology physicians in Plainview?
Dr. Haberman's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Haberman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Plainview
Browse urology physicians in Plainview ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology